Sailing On A Wave Of New Research.

Summarizes topics discussed at the 65th Annual Meeting and Sessions of the American Diabetes Association held in San Diego, California in June 2005. Ability of type 1 diabetics to lower their risk of developing cardiovascular disease, according to the findings of the Diabetes Control and Complications Trial; Effect of the weight-loss drug Acomplia developed by Sanofi-Aventis on obese people with type 2 diabetes; Reasons behind the high rate of type 2 diabetes among the Pima Indians, a native American tribe in Arizona, according to a study by the U.S. National Institutes of Health.